Viewing Protocol Section

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT06102174
Ignite Creation Date: 2024-05-06 @ 7:42 PM
Last Modification Date: 2024-10-26 @ 3:12 PM
Study NCT ID: NCT06102174
Protocol Section: NCT06102174
Start Identification Module Data
Expand Identification Module Data
Brief Title: A Study to Learn About the Amount of the Study Medicine Sisunatovir in Blood and Its Safety in Infants and Children With Pneumonia Caused by RSV
Official Title: AN INTERVENTIONAL PHASE 1b RANDOMIZED DOUBLE-BLIND SPONSOR-OPEN PLACEBO-CONTROLLED MULTI-CENTER DOSE-FINDING STUDY TO EVALUATE SAFETY TOLERABILITY AND PHARMACOKINETICS OF SISUNATOVIR IN PEDIATRIC PARTICIPANTS UP TO AGE 60 MONTHS WITH RESPIRATORY SYNCYTIAL VIRUS RSV LOWER RESPIRATORY TRACT INFECTION LRTI
Acronym: None
Organization: Pfizer
Organization Class: INDUSTRY
Organization Study ID: C5241009
Secondary IDs
Secondary ID Type Domain Link
2023-504425-39-00 REGISTRY CTIS EU None
Start Status Module Data
Status Verified Date: 2024-10
Overall Status: TERMINATED
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Pfizer
Lead Sponsor Class: INDUSTRY
Lead Sponsor: Pfizer
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload